• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

气道微生物群与慢性阻塞性肺疾病的急性加重

The airway microbiota and exacerbations of COPD.

作者信息

Leiten Elise Orvedal, Nielsen Rune, Wiker Harald Gotten, Bakke Per Sigvald, Martinsen Einar Marius Hjellestad, Drengenes Christine, Tangedal Solveig, Husebø Gunnar Reksten, Eagan Tomas Mikal Lind

机构信息

Dept of Clinical Science, University of Bergen, Bergen, Norway.

Dept of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.

出版信息

ERJ Open Res. 2020 Aug 31;6(3). doi: 10.1183/23120541.00168-2020. eCollection 2020 Jul.

DOI:10.1183/23120541.00168-2020
PMID:32904583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7456643/
Abstract

AIM

The aim of this study was to investigate whether the compositionality of the lower airway microbiota predicts later exacerbation risk in persons with COPD in a cohort study.

MATERIALS AND METHODS

We collected lower airways microbiota samples by bronchoalveolar lavage and protected specimen brushes, and oral wash samples from 122 participants with COPD. Bacterial DNA was extracted from all samples, before we sequenced the V3-V4 region of the 16S RNA gene. The frequency of moderate and severe COPD exacerbations was surveyed in telephone interviews and in a follow-up visit. Compositional taxonomy and α and β diversity were compared between participants with and without later exacerbations.

RESULTS

The four most abundant phyla were Firmicutes, Bacteroidetes, Proteobacteria and Fusobacteria in both groups, and the four most abundant genera were , , and . The relative abundances of different taxa showed a large variation between samples and individuals, and no statistically significant difference of either compositional taxonomy, or α or β diversity could be found between participants with and without COPD exacerbations within follow-up.

CONCLUSION

The findings from the current study indicate that individual differences in the lower airway microbiota in persons with COPD far outweigh group differences between frequent and nonfrequent COPD exacerbators, and that the compositionality of the microbiota is so complex as to present large challenges for use as a biomarker of later exacerbations.

摘要

目的

本研究旨在通过一项队列研究,调查下呼吸道微生物群的组成是否能预测慢性阻塞性肺疾病(COPD)患者日后的急性加重风险。

材料与方法

我们通过支气管肺泡灌洗和保护性标本刷收集了122例COPD患者的下呼吸道微生物群样本以及口腔冲洗样本。在对16S RNA基因的V3 - V4区域进行测序之前,从所有样本中提取细菌DNA。通过电话访谈和随访调查了中度和重度COPD急性加重的发生频率。比较了有和没有日后急性加重的参与者之间的组成分类以及α和β多样性。

结果

两组中最丰富的四个门均为厚壁菌门、拟杆菌门、变形菌门和梭杆菌门,最丰富的四个属分别为 、 、 和 。不同分类群的相对丰度在样本和个体之间存在很大差异,在随访期间,有和没有COPD急性加重的参与者之间,无论是组成分类还是α或β多样性,均未发现统计学上的显著差异。

结论

本研究结果表明,COPD患者下呼吸道微生物群的个体差异远远超过频繁和不频繁COPD急性加重者之间的组间差异,并且微生物群的组成非常复杂,以至于作为日后急性加重的生物标志物面临巨大挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/f8e07456b297/00168-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/cb9ce72ea355/00168-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/22df6979aaea/00168-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/5788abbd2d77/00168-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/f8e07456b297/00168-2020.04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/cb9ce72ea355/00168-2020.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/22df6979aaea/00168-2020.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/5788abbd2d77/00168-2020.03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f70c/7456643/f8e07456b297/00168-2020.04.jpg

相似文献

1
The airway microbiota and exacerbations of COPD.气道微生物群与慢性阻塞性肺疾病的急性加重
ERJ Open Res. 2020 Aug 31;6(3). doi: 10.1183/23120541.00168-2020. eCollection 2020 Jul.
2
The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.与健康人群相比,印度人群中中度和重度 COPD 加重患者的痰液微生物组谱发生了改变。
F1000Res. 2023 Oct 27;12:528. doi: 10.12688/f1000research.132220.3. eCollection 2023.
3
Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.慢性阻塞性肺疾病患者临床稳定期痰液微生物组与加重表型的相关性研究。
J Transl Med. 2021 Mar 23;19(1):121. doi: 10.1186/s12967-021-02788-4.
4
Diversity of Fungi and Bacteria in Bronchoalveolar Lavage Fluid during Development of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病发展过程中支气管肺泡灌洗液中真菌和细菌的多样性
Jpn J Infect Dis. 2022 Nov 22;75(6):560-568. doi: 10.7883/yoken.JJID.2022.153. Epub 2022 Jul 29.
5
Exploring protocol bias in airway microbiome studies: one versus two PCR steps and 16S rRNA gene region V3 V4 versus V4.探索气道微生物组研究中的方案偏倚:一步法与两步法PCR以及16S rRNA基因区域V3 V4与V4的比较
BMC Genomics. 2021 Jan 4;22(1):3. doi: 10.1186/s12864-020-07252-z.
6
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的气道微生物群动态变化
J Clin Microbiol. 2014 Aug;52(8):2813-23. doi: 10.1128/JCM.00035-14. Epub 2014 May 21.
7
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.慢性阻塞性肺疾病上呼吸道微生物群落 α 多样性与加重表型相关:一项病例对照观察性研究。
Respir Res. 2019 Jun 7;20(1):114. doi: 10.1186/s12931-019-1080-4.
8
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers.稳定期慢性阻塞性肺疾病、吸烟者和健康非吸烟者的社区动态与下呼吸道微生物群。
Thorax. 2016 Sep;71(9):795-803. doi: 10.1136/thoraxjnl-2015-207235. Epub 2016 May 4.
9
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.AERIS 研究中的肺部微生物组纵向分析表明细菌和嗜酸性 COPD 加重具有可重复性。
Thorax. 2018 May;73(5):422-430. doi: 10.1136/thoraxjnl-2017-210408. Epub 2018 Jan 31.
10
Alveolar microbiota profile in patients with human pulmonary tuberculosis and interstitial pneumonia.肺泡微生物组在人肺结核和间质性肺炎患者中的特征。
Microb Pathog. 2020 Feb;139:103851. doi: 10.1016/j.micpath.2019.103851. Epub 2019 Nov 9.

引用本文的文献

1
The impact of environmental factors on respiratory tract microbiome and respiratory system diseases.环境因素对呼吸道微生物群和呼吸系统疾病的影响。
Eur J Med Res. 2025 Apr 4;30(1):236. doi: 10.1186/s40001-025-02517-3.
2
Burn inhalation injury and intubation with dexamethasone-eluting endotracheal tubes modulate local microbiome and alter airway inflammation.烧伤吸入性损伤及使用地塞米松洗脱气管导管插管可调节局部微生物群并改变气道炎症。
Front Bioeng Biotechnol. 2025 Feb 26;13:1524013. doi: 10.3389/fbioe.2025.1524013. eCollection 2025.
3
Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression.

本文引用的文献

1
Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.稳定期和慢性阻塞性肺疾病(COPD)患者加重期痰液微生物群和炎症。
PLoS One. 2019 Sep 17;14(9):e0222449. doi: 10.1371/journal.pone.0222449. eCollection 2019.
2
Laboratory contamination in airway microbiome studies.气道微生物组研究中的实验室污染。
BMC Microbiol. 2019 Aug 14;19(1):187. doi: 10.1186/s12866-019-1560-1.
3
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.
微生物群-黏膜免疫关系:呼吸系统疾病进展的驱动因素
J Microbiol. 2024 Sep;62(9):709-725. doi: 10.1007/s12275-024-00167-4. Epub 2024 Sep 6.
4
Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study.慢性阻塞性肺疾病急性加重期患者呼吸道中的细菌种类及炎性细胞变异性:一项多中心研究
Infect Drug Resist. 2023 Apr 11;16:2107-2115. doi: 10.2147/IDR.S402828. eCollection 2023.
5
Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study.慢性阻塞性肺疾病加重期的早期诊断生物标志物:探索性、前瞻性、纵向、单中心、观察性 MARKED 研究方案。
BMJ Open. 2023 Mar 3;13(3):e068787. doi: 10.1136/bmjopen-2022-068787.
6
Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.慢性阻塞性肺疾病的频繁急性加重者在临床稳定期有可区分的痰液微生物组特征。
Front Microbiol. 2022 Dec 1;13:1037037. doi: 10.3389/fmicb.2022.1037037. eCollection 2022.
7
The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis.气道下部微生物群和抗菌肽表明类肉瘤病存在菌群失调。
Microbiome. 2022 Oct 19;10(1):175. doi: 10.1186/s40168-022-01362-4.
8
Impact of Lung Microbiota on COPD.肺部微生物群对慢性阻塞性肺疾病的影响。
Biomedicines. 2022 Jun 6;10(6):1337. doi: 10.3390/biomedicines10061337.
9
Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome.绘制人类呼吸道微生物组的细菌多样性和代谢功能图谱。
J Oral Microbiol. 2022 Mar 16;14(1):2051336. doi: 10.1080/20002297.2022.2051336. eCollection 2022.
10
The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.特发性肺纤维化的下呼吸道微生物组和抗菌肽与慢性阻塞性肺疾病不同。
PLoS One. 2022 Jan 6;17(1):e0262082. doi: 10.1371/journal.pone.0262082. eCollection 2022.
使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
4
Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.COPD 患者呼吸微生物组与气流受限严重程度、加重病史和循环嗜酸性粒细胞的关系。
BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.
5
Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.慢性阻塞性肺疾病上呼吸道微生物群落 α 多样性与加重表型相关:一项病例对照观察性研究。
Respir Res. 2019 Jun 7;20(1):114. doi: 10.1186/s12931-019-1080-4.
6
Airway host-microbiome interactions in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道宿主-微生物组相互作用。
Respir Res. 2019 Jun 6;20(1):113. doi: 10.1186/s12931-019-1085-z.
7
Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data.简单的统计鉴定和去除标记基因和宏基因组数据中的污染物序列。
Microbiome. 2018 Dec 17;6(1):226. doi: 10.1186/s40168-018-0605-2.
8
Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status.转录活跃的肺部微生物群及其与细菌生物量和宿主炎症状态的关联。
mSystems. 2018 Oct 30;3(5). doi: 10.1128/mSystems.00199-18. eCollection 2018 Sep-Oct.
9
Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations.痰微生物组与慢性阻塞性肺疾病住院后 1 年的死亡率相关。
Am J Respir Crit Care Med. 2019 May 15;199(10):1205-1213. doi: 10.1164/rccm.201806-1135OC.
10
Exacerbation induces a microbiota shift in sputa of COPD patients.加重会引起 COPD 患者痰液中的微生物群落发生变化。
PLoS One. 2018 Mar 26;13(3):e0194355. doi: 10.1371/journal.pone.0194355. eCollection 2018.